Screening of anti-carcinogenic properties of phytocompounds from Moroccan Marrubium vulgare for treating breast and prostate cancer through in silico approaches
-
Amal Bouribab
,
El Mehdi Karim
Abstract
Breast and prostate cancers are among the most prevalent cancers worldwide, with current treatments often limited by reduced efficacy and adverse side effects. In search of safer and more effective alternatives, Marrubium vulgare L., a medicinal plant traditionally used for its therapeutic benefits, was investigated for its anticancer potential. This study employed a comprehensive in silico approach combining virtual screening, molecular docking, ADMET prediction, DFT calculations, and molecular dynamics simulations to evaluate the interaction of 56 phytochemicals from M. vulgare with two cancer-related targets: the androgen receptor (prostate cancer) and β-tubulin (breast cancer). Docking analysis revealed six compounds with high affinity for the androgen receptor, achieving binding scores between −11.4 and −8.3 kcal/mol. Similarly, eight compounds showed stronger interactions with β-tubulin than the standard drug paclitaxel, with binding energies ranging from −7.4 to −6.1 kcal/mol. Among these, compounds L31, L39, L43, and L46 displayed favorable toxicity profiles, with no predicted toxic effects. Notably, molecular dynamics simulations confirmed the stability of L31 as a potent androgen receptor inhibitor, while L39 and L46 showed promising interactions with β-tubulin, and DFT calculations provided additional insights into the electronic properties of the lead compounds. Overall, this study highlights the promising anticancer potential of phytoconstituents from Moroccan M. vulgare as candidates for further in vitro and in vivo evaluation.
-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Conflict of interest: The author states no conflict of interest.
-
Research funding: None declared.
-
Data availability: Not applicable.
References
1. Silva Franklyn, D, Alcorn, J. A tale of two cancers: a current concise overview of breast and prostate cancer. Cancers 2022;14.10.3390/cancers14122954Search in Google Scholar PubMed PubMed Central
2. Lamphar, H, Kocifaj, M, Limón-Romero, J, Paredes-Tavares, J, Chakameh, SD, Mego, M, et al.. Light pollution as a factor in breast and prostate cancer. Sci Total Environ 2022;806:150918.10.1016/j.scitotenv.2021.150918Search in Google Scholar PubMed
3. Homewood, D, Hei Fu, M, Sathianathen, N, La Bianca, S, Tran, B, Corcoran, NM. Evolution of hormonal therapy for prostate cancer. Australian J General Practice 2024.10.31128/AJGP-11-23-7028Search in Google Scholar PubMed
4. Simon Israel, J, Marcelin, L-M, Thomas, C, Szczyrbová, E, Fuessel, S, Puhr, M, et al.. Emerging frontiers in androgen receptor research for prostate cancer: insights from the 2nd international androgen receptor symposium. J Exp Clin Cancer Res ; 2024;43:194.10.1186/s13046-024-03125-5Search in Google Scholar PubMed PubMed Central
5. Ren, L, Zhang, T, Zhang, J. Recent advances in dietary androgen receptor inhibitors. Med Res Rev 2024;44:1446–500.10.1002/med.22019Search in Google Scholar PubMed
6. Xiong, X, Zheng, L-W, Ding, Y, Chen, Y-F, Cai, Y-W, Wang, L-P, et al.. Breast cancer: pathogenesis and treatments. Signal Transduct Targeted Ther 2025;10:49.10.1038/s41392-024-02108-4Search in Google Scholar PubMed PubMed Central
7. Kanakkanthara, A, Miller, JH. βIII-tubulin overexpression in cancer: causes, consequences, and potential therapies. Biochim Biophys Acta Rev Cancer 2021;1876:188607.10.1016/j.bbcan.2021.188607Search in Google Scholar PubMed
8. Tien, AH, Sadar, MD. Treatments targeting the androgen receptor and its splice variants in breast cancer. Int J Mol Sci 2024;25:1817.10.3390/ijms25031817Search in Google Scholar PubMed PubMed Central
9. Benhima, N, Afani, L, El Fadli, M, Essâdi, I, Belbaraka, R. Investigating the availability, affordability, and market dynamics of innovative oncology drugs in Morocco: an original report. Int J Equity Health 2024;23:217.10.1186/s12939-024-02262-9Search in Google Scholar PubMed PubMed Central
10. Samar Hasan, S, Resheed Behayaa, H, Al-Baaj, AFF, Ewadh, MM, Abd Zaid, S, Ewadh, MM, et al.. The diagnostic and prognostic value of Kinesin-4A protein, β-Tubulin protein, and exosomes as non-invasive biomarkers in Iraqi women with breast cancer. Med J Babylon 2024;21:832–7.10.4103/MJBL.MJBL_652_23Search in Google Scholar
11. Idm’hand Elhassan, Msanda, F, Cherifi, K. Ethnopharmacological review of medicinal plants used to manage diabetes in Morocco. Clin Phytoscience 2020;6:1–32.10.1186/s40816-020-00166-zSearch in Google Scholar
12. Maideen, NMP, Ben Hadda, T, Almalki, FA, Moueqquit, M, Kawsar, SMA. Black seeds (Nigella sativa) for the management of COVID-19 in pregnant and breastfeeding women: an insight. J Compl Alternative Med Res 2023;3:14–26.10.9734/jocamr/2023/v23i2473Search in Google Scholar
13. M Ibrahim, A Agour, N Hamamouch, B Lyoussi, and E Derwich. Chemical composition and in vitro antioxidant and antimicrobial activities of Marrubium vulgare L. Sci World J. 2021.1. 7011493. 2021.10.1155/2021/7011493Search in Google Scholar PubMed PubMed Central
14. Jaadan, H, Akodad, M, Moumen, A, Baghour, M, Skalli, A, Ezrari, S, et al.. Phytochemical screening, polyphenols, flavonoids and tannin content, antioxidant activities and FTIR characterization of Marrubium vulgare L. from 2 different localities of northeast of Morocco. Heliyon 2020;6. https://doi.org/10.1016/j.heliyon.2020.e05609.Search in Google Scholar PubMed PubMed Central
15. Bouchra, R, Bouribab, A, Abchir, O, Khedraoui, M, El Kouali, M, Chtita, S. Antidiabetic potential of Moroccan medicinal plant extracts: a virtual screening using in silico approaches. Results Chem 2025;16:102365.10.1016/j.rechem.2025.102365Search in Google Scholar
16. Islam, MR, Islam, F, Nafady, MH, Akter, M, Mitra, S, Das, R, et al.. Natural small molecules in breast cancer treatment: understandings from a therapeutic viewpoint. Molecules 2022;27:2165.10.3390/molecules27072165Search in Google Scholar PubMed PubMed Central
17. Amal, B, Karim, EM, Khedraoui, M, Abchir, O, Errougui, A, Raouf, YS, et al.. Exploring Moroccan medicinal plants for anticancer therapy development through in Silico studies. Pharmaceuticals 2024;17:1528.10.3390/ph17111528Search in Google Scholar PubMed PubMed Central
18. Bouribab, A, Errougui, A, Chtita, S. CADD methods for developing novel compounds synthesized to inhibit tyrosine kinase receptors. Curr Top Med Chem 2025;25:1141–64.10.2174/0115680266312422240712053821Search in Google Scholar PubMed
19. Prinsa, SS, Haque Bulbul, MZ, Ozeki, Y, Alamri, MA, Kawsar, SMA. Flavonoids as potential KRAS inhibitors: DFT, molecular docking, molecular dynamics simulation and ADMET analyses. J Asian Nat Prod Res 2024;26:955–92.10.1080/10286020.2024.2343821Search in Google Scholar PubMed
20. Bilal, S, Ahmad, S, Lee, J, Jung, C, Na, D. In silico methods and tools for drug discovery. Comput Biol Med 2021;137:104851.10.1016/j.compbiomed.2021.104851Search in Google Scholar PubMed
21. Quayum, ST, Esha, NJI, Siraji, S, Abbad, SSA, Alsunaidi, ZHA, Almatarneh, MH, et al.. Exploring the effectiveness of flavone derivatives for treating liver diseases: utilizing DFT, molecular docking, and molecular dynamics techniques. MethodsX 2024;12:102537.10.1016/j.mex.2023.102537Search in Google Scholar PubMed PubMed Central
22. Iwaloye, O, Ottu, PO, Olawale, F, Oyewole Babalola, O, Olalekan Elekofehinti, O, Kikiowo, B, et al.. Computer-aided drug design in anti-cancer drug discovery: what have we learnt and what is the way forward? Inform Med Unlocked 2023;41:101332.10.1016/j.imu.2023.101332Search in Google Scholar
23. Guerguer, FZ, Khedraoui, M, Samadi, A, Chtita, S. Computational approaches for multitarget drug design in Alzheimer’s disease: a comprehensive review. Curr Med Chem 2025;32:7017–44.10.2174/0109298673320300240930064551Search in Google Scholar PubMed
24. Bouchra, R, Abchir, O, El Kouali, M, Chtita, S. Advancements in computational approaches for antidiabetic drug discovery: a review. Curr Top Med Chem 2024;25:1123–40.10.2174/0115680266311132240807065631Search in Google Scholar PubMed
25. Mebarka, O, Bourougaa, L, Al-Mijalli, SH, Abdallah, EM, Bhat, AR, Kawsar, SMA. Marine-derived compounds as potential inhibitors of Hsp90 for anticancer and antimicrobial drug development: a comprehensive in silico study. Molecules 2023;28:8074.10.3390/molecules28248074Search in Google Scholar PubMed PubMed Central
26. Ibrahim, M, Agour, A, Lefrioui, Y, Mohamed, C. LC-TOFMS analysis, in vitro and in silico antioxidant activity on NADPH oxidase, and toxicity assessment of an extract mixture based on Marrubium vulgare L. and Dittrichia viscosa L. J Biol Biomed Res 2024;1. Article 1.10.69998/j2br2Search in Google Scholar
27. Ahmed, T, El Hamdaoui, L, Bouyahya, A, El Moussaouiti, M, Bakri, Y. Chemical composition, In Vitro cytotoxic, and antibacterial activities of Moroccan medicinal plants Euphorbia resinifera and Marrubium vulgare. Biointerface Res Appl Chem 2020;10:7343–55.10.33263/BRIAC106.73437355Search in Google Scholar
28. Rached, S, Imtara, H, Habsaoui, A, Mzioud, K, Haida, S, Saleh, A, et al.. Characterization, chemical compounds and biological activities of Marrubium vulgare L. essential oil. Processes 2022;10. Article 10.10.3390/pr10102110Search in Google Scholar
29. Bohl, CE, Gao, W, Miller, DD, Bell, CE, Dalton, JT. Structural basis for antagonism and resistance of bicalutamide in prostate cancer. Proc Natl Acad Sci 2005;102:6201–6. https://doi.org/10.1073/pnas.0500381102.Search in Google Scholar PubMed PubMed Central
30. Prota, AE, Magiera, MM, Kuijpers, M, Bargsten, K, Frey, D, Wieser, M, et al.. Structural basis of tubulin tyrosination by tubulin tyrosine ligase. JCB (J Cell Biol) 2013;200:259–70. https://doi.org/10.1083/jcb.201211017.Search in Google Scholar PubMed PubMed Central
31. Fatima Zahra, G, Bouribab, A, Karim, EM, Khedraoui, M, Amegrissi, F, Raouf, YS, et al.. Moroccan natural products for multitarget-based treatment of Alzheimer’s disease: a computational study. PLoS One 2025;20:e0313411.10.1371/journal.pone.0313411Search in Google Scholar PubMed PubMed Central
32. El Mehdi, K, Abchir, O, Nour, H, Yamari, I, Bennani, L, El Kouali, M, et al.. Discovery of a potential inhibitor against lung cancer: computational approaches and molecular dynamics study. Phys Chem Res 2024;12:579–89.Search in Google Scholar
33. Bouamri Lamiae, E, Bouachrine, M, Chtita, S. Computational studies in dermo-cosmetics: in Silico discovery of therapeutic agents targeting a variety of proteins for skin diseases. Curr Top Med Chem 2024;25:657–88.10.2174/0115680266337405240926114604Search in Google Scholar PubMed
34. Lipinski, CA, Lombardo, F, Dominy, BW, Feeney Paul, J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3–25. https://doi.org/10.1016/s0169-409x-00-00129-0.Search in Google Scholar
35. Schrödinger Release 2025-3: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2024. Maestro-Desmond Interoperability Tools, Schrödinger, New York, NY, 2025.Search in Google Scholar
36. Naik, HN, Kanjariya, D, Parveen, S, Meena, A, Ahmad, I, Patel, H, et al.. Dalbergia sissoo phytochemicals as EGFR inhibitors: an in vitro and in silico approach. J Biomol Struct Dyn 2024;42:5415–27.10.1080/07391102.2023.2229437Search in Google Scholar PubMed
37. Mohamed, AS, Elmi, A, Spina, R, Kordofani, MAY, Laurain-Mattar, D, Nour, H, et al.. In vitro and in silico analysis for elucidation of antioxidant potential of Djiboutian Avicennia Marina (Forsk.) Vierh. Phytochemicals. J Biomol Struct Dyn 2024;42:3410–25.10.1080/07391102.2023.2213338Search in Google Scholar PubMed
38. Matin, MA, Islam, MM, Thomas, B, Aziz, MA. The effects of oxidation states, spin states and solvents on molecular structure, stability and spectroscopic properties of Fe-catechol complexes: a theoretical study. Adv Chem Eng Sci 2017;7.10.4236/aces.2017.72011Search in Google Scholar
39. Becke Axel, D. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev 1988;38:3098. https://doi.org/10.1103/physreva.38.3098.Search in Google Scholar PubMed
40. Lee, C, Yang, W, Parr, RG. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 1988;37:785. https://doi.org/10.1103/physrevb.37.785.Search in Google Scholar PubMed
41. Jaikanth, C, Yogeetha, S, Shankar, K, Dickson, M, Laya, SKS, Ramanathan, L, et al.. Broadening the scope of WEE1 inhibitors: identifying novel drug candidates via computational approaches and drug repurposing. J Biomol Struct Dyn 2024;42:9337–47.10.1080/07391102.2023.2251070Search in Google Scholar PubMed
42. Mendapara, JV, Vaghasiya, MD, Rajani Dhanji, P, Ahmad, I, Patel, H, Premlata, K. Benzimidazole and piperidine containing novel 1,2,3-triazole hybrids as anti-infective agents: design, synthesis, in silico and in vitro antimicrobial efficacy. J Biochem Mol Toxicol 2024;38:e23526.10.1002/jbt.23526Search in Google Scholar PubMed
43. S Bishal, IM Aminul, HM Al Amin, A Iqrar, MA Al, G Sibdas, Rahman, A, HM Shohorab, AM Ashikujjaman, HM Rayhanul, HM Khalid, Mamun M., Haque, MA, Patel, H, PM Yeasin, Bhattacharya, P, and HM Azizul. Characterization of lignin and hemicellulose degrading bacteria isolated from cow rumen and forest soil: unveiling a novel enzymatic model for rice straw deconstruction. Sci Total Environ. 904. 166704. 2023.10.1016/j.scitotenv.2023.166704Search in Google Scholar PubMed
44. Kanjariya, DC, Naik, HN, Sherashiya, MJ, Naliapara, YT, Ahmad, I, Patel, H, et al.. α-Amylase and Mycobacterium-TB H37Rv antagonistic efficacy of novel pyrazole-coumarin hybrids: an in vitro and in silico investigation. J Biomol Struct Dyn 2024;42:12788–805.10.1080/07391102.2023.2273436Search in Google Scholar PubMed
45. Kaushik Kumar, B, Ahmad, I, Pati, S, Ghosh, A, Rabha, B, Sarkar, T, et al.. Screening of phytocompounds for identification of prospective histone deacetylase 1 (HDAC1) inhibitor: an in silico molecular docking, molecular dynamics simulation, and MM-GBSA approach. Appl Biochem Biotechnol 2024;196:3747–64.10.1007/s12010-023-04731-3Search in Google Scholar PubMed
46. Janmejaya, N, Janmejaya, R, Manjari, PS, Umakanta, T. Phytoconstituents of Ashwagandha as potential inhibitors of human islet amyloid polypeptide (hIAPP): an in silico investigation. J Biomol Struct Dyn 2023;42:11020–36.10.1080/07391102.2023.2259491Search in Google Scholar PubMed
47. Manjari, PS, Janmejaya, N, Umakanta, T. In Silico screening and identifying phytoconstituents of Withania somnifera as potent inhibitors of BRCA1 mutants: a therapeutic against breast cancer. Int J Biol Macromol 2024;282:136977.10.1016/j.ijbiomac.2024.136977Search in Google Scholar PubMed
48. Avigyan, N, Bhanja Kousik, K, Roy, RK, Niladri, P. Structural insight into G2019S mutated LRRK2 kinase and brain-penetrant type I inhibitor complex: a molecular dynamics approach. J Biomol Struct Dyn 2023;42:10129–49.10.1080/07391102.2023.2255675Search in Google Scholar PubMed
49. Janmejaya, R, Chandra, SB, Suchismita, S, Prasad, MP, Harekrushna, S, Umakanta, T. Conformational dynamics of myoglobin in the presence of vitamin B12: a spectroscopic and In silico investigation. Int J Biol Macromol 2021;192:564–73.10.1016/j.ijbiomac.2021.10.030Search in Google Scholar PubMed
50. Desai, NC, Shah, KN, Monapara, J, Dave, BP, Ahmad, I, Patel, H. Design, synthesis, biological profile and molecular modeling and MD simulation studies of heterocyclic benzimidazole and thiazolidine-4-one based 5-arylidene analogues as prospective antimicrobial agents. J Mol Struct 2024;1299:137166.10.1016/j.molstruc.2023.137166Search in Google Scholar
51. Kumar Bharadwaj, K, Rabha, B, Ahmad, I, Mathew, SP, Bhattacharjee, CK, Grace Jaganathan, B, et al.. Rhamnetin, a nutraceutical flavonoid arrests cell cycle progression of human ovarian cancer (SKOV3) cells by inhibiting the histone deacetylase 2 protein. J Biomol Struct Dyn 2024;42:13421–36.10.1080/07391102.2023.2275187Search in Google Scholar PubMed
52. Rossafi, B, Outahar, F, Hammoudan, I, Moumou, M, Touti, R, Ahmed, B, et al.. Mechanism and stereoselectivity of epoxidation reaction of a β-himachalene derivative: insights from DFT, molecular docking, ADMET, and molecular dynamics investigations. J Mol Struct 2024:139664.10.1016/j.molstruc.2024.139664Search in Google Scholar
53. Khedraoui, M, Abchir, O, Nour, H, Yamari, I, Errougui, A, Samadi, A, et al.. An in silico study based on QSAR and molecular docking and molecular dynamics simulation for the discovery of novel potent inhibitor against AChE. Pharmaceuticals 2024;17.10.3390/ph17070830Search in Google Scholar PubMed PubMed Central
54. MR Kachmar, HN Mrabti, M Bellahmar, A Ouahbi, Z Haloui, K El Badaoui, et al.. Traditional knowledge of medicinal plants used in the northeastern part of Morocco. Evid base Compl Alternative Med. 2021.1. 6002949. 2021.10.1155/2021/6002949Search in Google Scholar PubMed PubMed Central
55. Allah Gourich, A, Touijer, H, Drioiche, A, Asbabou, A, Remok, F, Saidi, S, et al.. Insight into biological activities of chemically characterized extract from Marrubium vulgare L.: in vitro, in vivo and in silico approaches. Front Chem 2023;11.10.3389/fchem.2023.1238346Search in Google Scholar PubMed PubMed Central
Supplementary Material
This article contains supplementary material (https://doi.org/10.1515/cppm-2025-0062).
© 2025 Walter de Gruyter GmbH, Berlin/Boston
